TIXiMED, Inc.

New Filing
CIK: 0002043713·Pharmaceuticals·DELAWARE·Filed: Nov 5, 2024
Total Offering

$550,000

Amount Sold

$550,000

Investors

3

First Sale

Oct 15, 2024

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Thomas Michael Goodrich II
Related Person
Aneth Shalev
Related Person

Company

TIXiMED, Inc.

1927 1ST AVENUE NORTH

BIRMINGHAM, AL, 35203

205-578-1005

SEC Filing

0002043713-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
TIXiMED, Inc. Form D Filing — $550,000 | FilingFlow